product summary
Loading...
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
CD34 Antibody (ICO-115)
catalog :
NBP2-29455
quantity :
0.1 mg (also 20 ug)
price :
379 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
ICO-115
reactivity :
human, rat
application :
ELISA, immunocytochemistry, flow cytometry
more info or order :
citations: 6
Reference
Vallant N, Sandhu B, Hamaoui K, Prendecki M, Pusey C, Papalois V. Immunomodulatory Properties of Mesenchymal Stromal Cells Can Vary in Genetically Modified Rats. Int J Mol Sci. 2021;22: pubmed publisher
Zhao Y, Li W, Song J, Zhang M, Huang T, Wei X. High expression of EphA2 led to secondary injury by destruction of BBB integrity though the ROCK pathway after diffuse axonal injury. Neurosci Lett. 2020;736:135234 pubmed publisher
Qi L, Ahmadi A, Huang J, Chen M, Pan B, Kuwabara H, et al. Major Improvement in Wound Healing Through Pharmacologic Mobilization of Stem Cells in Severely Diabetic Rats. Diabetes. 2020;69:699-712 pubmed publisher
Zhao Y, Wei X, Song J, Zhang M, Huang T, Qin J. Peroxisome Proliferator-Activated Receptor γ Agonist Rosiglitazone Protects Blood-Brain Barrier Integrity Following Diffuse Axonal Injury by Decreasing the Levels of Inflammatory Mediators Through a Caveolin-1-Dependent Pathway. Inflammation. 2019;42:841-856 pubmed publisher
Braun R, Chetty C, Balasubramaniam V, Centanni R, Haraldsdottir K, Hematti P, et al. Intraperitoneal injection of MSC-derived exosomes prevent experimental bronchopulmonary dysplasia. Biochem Biophys Res Commun. 2018;503:2653-2658 pubmed publisher
Wang M, Nestvold J, Rekdal Ø, Kvalheim G, Fodstad Ø. A novel rat fibrosarcoma cell line from transformed bone marrow-derived mesenchymal stem cells with maintained in vitro and in vivo stemness properties. Exp Cell Res. 2017;352:218-224 pubmed publisher
product information
brand :
Novus
master code :
NBP2-29455
SKU :
NBP2-29455
product name :
CD34 Antibody (ICO-115)
description :
The CD34 Antibody (ICO-115) from NBP2-29455 is a nbp2-29455 antibody to . This antibody reacts with adaptive immunity, angiogenesis, b cell development and differentiation markers, breast cancer, cancer, cell biology, cellular markers, endothelial cell markers, hematopoietic stem cell markers, hypoxia, immunology, innate immunity, mast cell markers, mesenchymal stem cell markers, myeloid cell markers, myeloid derived suppressor cell, neuronal cell markers, neuroscience, stem cell markers, tumor suppressors. The CD34 Antibody (ICO-115) has been validated for the following applications: P28906.
target :
CD34
category :
Primary Antibodies
unit sizes :
0.1 mg (also 20 ug)
buffer :
10 mM PBS with 0.05% BSA
clonality :
Monoclonal
clone :
ICO-115
concentration :
0.2 mg/ml
conjugate :
Unconjugated
host :
Mouse
immunogen :
Blast cells of a chronic myeloid leukemia patient
isotype :
IgG1 Kappa
purity :
Protein A or G purified
species :
Human, Rat
specificity :
This antibody recognizes a single chain, transmembrane, heavily glycosylated protein of 90-120kDa, which is identified as CD34
gene symbol :
CD34
accessionNumbers :
P28906
applications :
Flow Cytometry, ELISA, Immunocytochemistry/Immunofluorescence
USD :
379 USD
alt names :
CD34 antigenhematopoietic progenitor cell antigen CD34, CD34 molecule
storage :
Store at 4C.
more info or order :
company information
Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com
3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.